Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Determine the Safety and Efficacy of VI-0521 in the Treatment of Obesity in an Adult Population With BMI ≥ 35

NCT00554216 is registered in ClinicalTrials.gov with VIVUS LLC as lead sponsor.

NCT NCT00554216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00554216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Determine the Safety and Efficacy of VI-0521 in the Treatment of Obesity in an Adult Population With BMI ≥ 35
Lead sponsor
VIVUS LLC
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2007
Completion date
May 31, 2009
Enrollment
1,267 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

obesity